Stockreport

Cancer Genetics down 28% on pricing equity offering [Seeking Alpha]

CANCER GENETICS  (CGIX) 
Last cancer genetics earnings: 11/19 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cancergenetics.com
PDF Cancer Genetics down 28% on pricing equity offering Cancer Genetics (NASDAQ: CGIX priced Underwriter over-allotment is an additional 2M shares. The offering is expected [Read more]